Indefinite Delivery Contract 36C10X24D0028
Award Date
9/30/24
Last Date to Order
9/29/29
Federal Agency
VA Strategic Acquisition Center Frederick
Awardee
Fulgent Therapeutics LLC
Ultimate Awardee
Fulgent Genetics, Inc.
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Service Contract Inventory
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Department of the Army Medical Command awarded multiple blanket purchase agreements to Fulgent Therapeutics LLC for genetic testing services. The agreements have a potential value of $950,000 and require the contractor to provide genetic testing and variant confirmation services using whole genome sequencing and deletion/duplication analysis next generation sequencing technology. Performance is to be provided to Tripler Army Medical Center in Hawaii through September 2025.
The original...
The Department of Veterans Affairs (VA) Strategic Acquisition Center-Frederick awarded an Indefinite Delivery, Indefinite Quantity (IDIQ) contract to Baylor Miraca Genetics Laboratories LLC, doing business as Baylor Genetics, for the provision of germline pharmacogenomics (PGx) molecular testing services. The $982,402.00 firm fixed-price task order has an ultimate completion date of September 29, 2025 and supports the VA's medical research and development efforts.
This IDIQ contract is part...
The U.S. Department of Veterans Affairs (VA) awarded a $130.7 million Indefinite Delivery Contract (IDC) to Foundation Medicine, Inc., a leading provider of genomic profiling and molecular analysis services, for specialized tumor molecular profiling services. This single-award IDC, with a completion date of September 12, 2029, aims to provide the VA's National Precision Oncology Program with comprehensive genomic profiling for both solid and hematological malignancies. The contracted services...
The Department of Veterans Affairs (VA) awarded an indefinite-delivery/indefinite-quantity (IDIQ) contract to Foundation Medicine, Inc., a foreign-owned for-profit organization, for genomic sequencing testing services. The potential contract value exceeds $111 million and does not utilize any set-aside designations.
Under this IDIQ contract, Foundation Medicine has been awarded multiple firm fixed price delivery orders to provide a range of genomic sequencing, next-generation sequencing...
The Department of Veterans Affairs (VA) Headquarters has awarded Akesogen, Inc.'s Tempus Labs division a $111 million indefinite delivery contract to provide genomic analysis services in support of the agency's Million Veteran Program biomedical research initiative. This single-award IDV, originally granted in 2020, facilitates the issuance of firm-fixed-price delivery orders for Tempus Labs to conduct genomic sequencing, DNA quality assessment, SNP genotyping, methylation analysis, and other...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 awarded a blanket purchase agreement to PreventionGenetics LLC for germline genetic testing services. Under multiple task orders from September 2021 through September 2024, PreventionGenetics will provide testing to support VA healthcare programs from its facilities in Salt Lake City, Utah. The single award agreement has a potential value of $6.9 million.
PreventionGenetics will utilize...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded a single-award indefinite delivery contract to Ambry Genetics Corporation to provide specialized genetic reference laboratory testing services in support of VA programs. The contract has a potential value of $2,085,930 and a period of performance through March 2026.
Under the contract, Ambry Genetics has been issued four firm-fixed price delivery orders to date for laboratory...
The federal contract IDV award, valued at up to $890,640.00, was issued by the Department of Veterans Affairs' (VA) Veterans Integrated Service Network 16 (VISN 16) to Veracyte, Inc., a for-profit provider of genomic testing services. The single-award IDV, awarded on October 1, 2024 with a potential completion date of September 30, 2029, will enable VISN 16 to efficiently access Veracyte's commercial laboratory capabilities for specialized pathology testing to support VA hospitals and clinics...
The federal contract IDV award to Veracyte, Inc. under the GSA's Medical Laboratory Testing and Analysis Services Schedule (FSS-621-II) enables multiple federal agencies, including the Department of Veterans Affairs (VA) and Defense Health Agency, to procure Veracyte's genomic testing services. The contract, valued at up to $2.3 million through July 2028, provides access to Veracyte's commercial laboratory capabilities for cancer screening and diagnosis, such as the Afirma Genomic Sequencing...
This Federal Supply Schedule (FSS) contract was awarded by the U.S. Department of Veterans Affairs (VA) to Otogenetics Corporation, a minority-owned small business, to provide medical laboratory testing and analysis services. The contract has a ceiling value of $225,000 and a period of performance through February 2030.
Under this contract, Otogenetics will provide a range of specialized laboratory services to support medical research programs within the VA and the National Institutes of...